Alto Neuroscience (ANRO) Reports FY25 Loss of $2.19/Share
Earnings Per Share (GAAP) $-2.19 vs $-0.41 est. Analyst sentiment remains constructive. Despite the loss, the analyst community maintains a ...
Earnings Per Share (GAAP) $-2.19 vs $-0.41 est. Analyst sentiment remains constructive. Despite the loss, the analyst community maintains a ...
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.